AZMAWELL 100 | Sacubitril and Valsartan Tablets
A high-strength breakthrough combination medication designed for the effective management of heart failure. AZMAWELL 100 combines two powerful active ingredients, Sacubitril and Valsartan, in a single, convenient tablet to help improve heart function and patient outcomes.
Key Benefits
-
Enhanced Dual-Action Power: Provides stronger suppression of harmful neurohormonal systems and enhanced protective pathways in the heart.
-
Superior Efficacy in Heart Failure: Clinically proven to significantly reduce the risk of cardiovascular death and hospitalization for heart failure.
-
Improved Quality of Life: Enables patients to breathe easier and engage in daily activities with reduced fatigue.
-
Optimal Convenience: Higher strength allows for simplified treatment regimens, improving patient adherence.
Indications
-
Treatment of chronic heart failure with reduced ejection fraction (HFrEF) in adults requiring higher dosage
-
Replacement therapy for ACE inhibitors or angiotensin II receptor blockers (ARB) under physician supervision
-
Integral component of a comprehensive heart failure management program
Possible Side Effects
Some patients may experience dizziness, lightheadedness, hyperkalemia (high potassium levels), mild cough, or renal impairment. Regular blood tests are essential to monitor kidney function and potassium levels. In rare cases, angioedema (swelling of the face, lips, or throat) may occur. Patients should immediately report any unusual symptoms to their healthcare provider.
Product Specifications
-
Brand Name: AZMAWELL 100
-
Composition: Sacubitril and Valsartan
-
Dosage Form: Film-Coated Tablets
-
Available Strengths: 100mg
-
Manufacturer: Nextwell Pharmaceuticals
AZMAWELL 100 – Advanced cardiac care for a stronger heart and a better life.
